# A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)

> **NCT01975051** · PHASE4 · COMPLETED · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 36 (actual)

## Conditions studied

- Post-kala-azar Dermal Leishmaniasis

## Interventions

- **DRUG:** Mitefosine

## Key facts

- **NCT ID:** NCT01975051
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01975051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01975051, "A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01975051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*